Plandai Biotechnology Inc (PLPL) – This is a publicly quoted shell company, headquartered in Nevada, that seeks to create value for shareholders by merging with other entities with experienced management and opportunities for growth.
They recently announced a non-binding letter of intent to enter into a new business through a proposed product and technology rights licensing agreement with the rights holder of Puriblood Leukocyte Reduction Blood Filtration System. The terms of the proposed agreement will include exclusive rights to the Puriblood technology for North, Central, and South America for a period of 30 years. Right now, about thirty countries around the world require these leuko-reduction blood supplies. This is a great time to invest in this penny stock.